The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients

被引:2
|
作者
Braga-Diniz, Julia Mourao [1 ]
Santa-Rosa, Caroline Christine [1 ]
Martins, Renata de Castro [2 ]
Souza e Silva, Maria Elisa [1 ]
Vieira, Leda Quercia [3 ]
Ribeiro Sobrinho, Antonio Paulino [1 ]
机构
[1] Univ Fed Minas Gerais, Sch Dent, Dept Operat Dent, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil
来源
BRAZILIAN ORAL RESEARCH | 2017年 / 31卷
关键词
Immunosuppression; Hematopoietic stem cell transplantation; Endodontics; DNA-DNA HYBRIDIZATION; MARROW-TRANSPLANTATION; GLOBAL PERSPECTIVE; INFECTIONS; MICROBIOTA; LEUKEMIA; RECIPIENTS; BACTERIA; DISEASE; BLOOD;
D O I
10.1590/1807-3107BOR-2017.vol31.0050
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The aim of this study is to investigate the relationship between the epidemiological and clinical profiles of patients before and after hematopoietic stem cell transplantation (HSCT) and the need for endodontic treatment. The subjects included 188 individuals enrolled in the dental care program for transplanted patients of the School of Dentistry, Federal University of Minas Gerais (Faculdade de Odontologia da Universidade Federal de Minas Gerais, FO-UFMG) from March 2011 through March 2016. The patients were subjected to an HSCT conditioning dental regimen based on a thorough clinical and radiographic evaluation. Intraoral periapical and bite-wing X-rays were obtained, and after evaluation, specific dental treatment was planned and performed. The following demographic and clinical data were collected from the patients' medical records: age, gender, transplantation stage, primary disease, transplant type, medication used, complete blood count at the time of visit, and need for endodontic treatment. The Kolmogorov-Smirnov and the chi-square tests were used. Leukemia (31.3%) and multiple myeloma (17.9%) were the most prevalent primary diseases. Most patients were subjected to allogeneic-related transplantation (83.6%). Most patients exhibited platelet counts and hemoglobin concentrations below the reference values in the pre-transplantation stage, while the neutrophil and platelet counts and the hemoglobin levels were within the reference ranges in the post-transplantation stage. The proportions of individuals requiring endodontic treatment were similar between the pre-and post-transplantation groups: 24.3% and 24.7%, respectively. The systemic conditions of the patients referred for dental treatment were compromised.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] Endodontic Treatment in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
    Mota, Maria Emilia
    Siqueira Jr, Jose F.
    Rocas, Isabela N.
    Alves, Fabio Abreu
    Jaguar, Graziella Chagas
    Franco, Juliana Bertoldi
    Schmidt Filho, Jayr
    Moreira, Maria Stella
    JOURNAL OF ENDODONTICS, 2025, 51 (01) : 35 - 42
  • [2] Hematopoietic stem cell transplantation in systemic sclerosis: Yes!! BUT ...
    AlOdhaibi, Khitam A.
    Varga, John
    Furst, Daniel E.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2021, 6 (01) : 44 - 49
  • [3] Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients
    Schwenk, Hayden T.
    Khan, Aslam
    Kohlman, Krystal
    Bertaina, Alice
    Cho, Stephanie
    Montoya, Jose G.
    Contopoulos-Ioannidis, Despina G.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (04): : 292 - 300
  • [4] Hematopoietic stem-cell transplantation in systemic sclerosis: an update
    Spierings, Julia
    van Rhijn-Brouwer, Femke C. C.
    van Laar, Jacob M.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (06) : 541 - 547
  • [5] Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
    Helbig, Grzegorz
    Widuchowska, Malgorzata
    Koclega, Anna
    Kopinska, Anna
    Kopec-Medrek, Magdalena
    Gawel, Wladyslaw B.
    Spalek, Adrianna
    Zak, Jakub
    Grygoruk-Wisniowska, Iwona
    Liwoch, Robert
    Kucharz, Eugeniusz
    Markiewicz, Miroslaw
    CLINICAL RHEUMATOLOGY, 2018, 37 (06) : 1709 - 1714
  • [6] Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus
    Alexander, T.
    Arnold, R.
    Hiepe, F.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (08): : 770 - 779
  • [7] Oral Care for Hematopoietic Stem Cell Transplantation Patients: A Narrative Review
    Samim, Firoozeh
    ten Bohmer, Kim L.
    Koppelmans, Renee G. A.
    Raber-Durlacher, Judith E.
    Epstein, Joel B.
    ORAL HEALTH & PREVENTIVE DENTISTRY, 2019, 17 (05) : 413 - 423
  • [8] Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?
    van Rhijn-Brouwer, Femke C. C.
    Spierings, Julia
    van Laar, Jacob M.
    IMMUNOLOGY LETTERS, 2018, 195 : 88 - 96
  • [9] Hematopoietic stem cell transplantation for systemic lupus erythematosus
    Burt, RK
    Traynor, AE
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (05) : 207 - 209
  • [10] Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
    Li, Zhen
    Zhang, Binglei
    Fan, Xinxin
    Gui, Ruirui
    Yu, Fengkuan
    Wang, Juan
    Zhang, Yanli
    Zhou, Keshu
    Liu, Yanyan
    Li, Yufu
    Ding, Jing
    Song, Yongping
    Zhou, Jian
    FRONTIERS IN ONCOLOGY, 2023, 13